HL7 Terminology (THO)
3.1.0 - Publication International flag

This page is part of the HL7 Terminology (v3.1.0: Release) based on FHIR R4. This is the current published version. For a full list of available versions, see the Directory of published versions

: Active Ingredient Group Number - TTL Representation

Active as of 2021-03-22

Raw ttl | Download


@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

 a fhir:NamingSystem;
  fhir:nodeRole fhir:treeRoot;
  fhir:Resource.id [ fhir:value "v3-hc-aign"];
  fhir:DomainResource.text [
     fhir:Narrative.status [ fhir:value "generated" ];
     fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><h3>Summary</h3><table class=\"grid\"><tr><td>Defining URL</td><td>http://terminology.hl7.org/NamingSystem/v3-hc-aign</td></tr><tr><td>Name</td><td>HcAIGN</td></tr><tr><td>Status</td><td>active</td></tr><tr><td>Definition</td><td><div><p>The AIG number is a 10 digit number that identifies products that have the same active ingredient(s) and ingredient strength(s). The AIG is comprised of three portions:</p>\n<ul>\n<li>the first portion (2 digits) identifies the number of active ingredients</li>\n<li>the second portion(5 digits) identifies the unique groups of active ingredients(s);</li>\n<li>the last portion (3 digits) identifies the active ingredient group strength. The strength group has a tolerance of -2% to +10%.</li>\n</ul>\n<p>Further information about this Code System can be found at https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database/terminology.html</p>\n</div></td></tr><tr><td>Publisher</td><td>Health Canada</td></tr></table><h3>Identifiers</h3><table class=\"grid\"><tr><td><b>Type</b></td><td><b>Value</b></td><td><b>Preferred</b></td><td><b>Period</b></td><td><b>Comment</b></td></tr><tr><td>OID</td><td>2.16.840.1.113883.5.1106</td><td>true</td><td></td><td/></tr><tr><td>URI</td><td>http://terminology.hl7.org/CodeSystem/v3-hc-aign</td><td>true</td><td>2021-03-22 --&gt; (ongoing)</td><td>Official canonical URL going forward.</td></tr><tr><td>URI</td><td>http://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database-4</td><td>false</td><td></td><td>Maintained for backward compatibility.</td></tr></table></div>"
  ];
  fhir:DomainResource.extension [
     fhir:index 0;
     fhir:Extension.url [ fhir:value "http://hl7.org/fhir/tools/StructureDefinition/extension-title" ];
     fhir:Extension.valueString [ fhir:value "Active Ingredient Group Number" ]
  ], [
     fhir:index 1;
     fhir:Extension.url [ fhir:value "http://hl7.org/fhir/5.0/StructureDefinition/extension-NamingSystem.url" ];
     fhir:Extension.valueUri [ fhir:value "http://terminology.hl7.org/NamingSystem/v3-hc-aign" ]
  ], [
     fhir:index 2;
     fhir:Extension.url [ fhir:value "http://terminology.hl7.org/StructureDefinition/ext-namingsystem-version" ];
     fhir:Extension.valueString [ fhir:value "3.0.0" ]
  ];
  fhir:NamingSystem.name [ fhir:value "HcAIGN"];
  fhir:NamingSystem.status [ fhir:value "active"];
  fhir:NamingSystem.kind [ fhir:value "codesystem"];
  fhir:NamingSystem.date [ fhir:value "2021-03-22T00:00:00-04:00"^^xsd:dateTime];
  fhir:NamingSystem.publisher [ fhir:value "Health Canada"];
  fhir:NamingSystem.contact [
     fhir:index 0;
     fhir:ContactDetail.name [ fhir:value "Health Canada" ]
  ];
  fhir:NamingSystem.responsible [ fhir:value "HL7 Canada"];
  fhir:NamingSystem.description [ fhir:value "The AIG number is a 10 digit number that identifies products that have the same active ingredient(s) and ingredient strength(s). The AIG is comprised of three portions: \r\n\r\n *  the first portion (2 digits) identifies the number of active ingredients\r\n *  the second portion(5 digits) identifies the unique groups of active ingredients(s);\r\n *  the last portion (3 digits) identifies the active ingredient group strength. The strength group has a tolerance of -2% to +10%.\r\n \r\n\r\nFurther information about this Code System can be found at https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database/terminology.html"];
  fhir:NamingSystem.uniqueId [
     fhir:index 0;
     fhir:NamingSystem.uniqueId.type [ fhir:value "oid" ];
     fhir:NamingSystem.uniqueId.value [ fhir:value "2.16.840.1.113883.5.1106" ];
     fhir:NamingSystem.uniqueId.preferred [ fhir:value "true"^^xsd:boolean ]
  ], [
     fhir:index 1;
     fhir:NamingSystem.uniqueId.type [ fhir:value "uri" ];
     fhir:NamingSystem.uniqueId.value [ fhir:value "http://terminology.hl7.org/CodeSystem/v3-hc-aign" ];
     fhir:NamingSystem.uniqueId.preferred [ fhir:value "true"^^xsd:boolean ];
     fhir:NamingSystem.uniqueId.comment [ fhir:value "Official canonical URL going forward." ];
     fhir:NamingSystem.uniqueId.period [
       fhir:Period.start [ fhir:value "2021-03-22"^^xsd:date ]     ]
  ], [
     fhir:index 2;
     fhir:NamingSystem.uniqueId.type [ fhir:value "uri" ];
     fhir:NamingSystem.uniqueId.value [ fhir:value "http://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database-4" ];
     fhir:NamingSystem.uniqueId.preferred [ fhir:value "false"^^xsd:boolean ];
     fhir:NamingSystem.uniqueId.comment [ fhir:value "Maintained for backward compatibility." ]
  ].

# - ontology header ------------------------------------------------------------

 a owl:Ontology;
  owl:imports fhir:fhir.ttl.